ORIC Pharmaceuticals Inc
Research ORIC Pharmaceuticals Inc (ORIC) on Bullrun: market cap USD 1.43B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerORIC
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 1.43B
- Financial periodQ2 2026
- RevenueUSD 0
- Net income-USD 41.49M
- Free cash flow-USD 31.96M
Valuation Snapshot
latest market cap is USD 1.43B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 129.47M | -USD 111.68M | n/a | -1.47 | USD 45.67M | USD 3.33M | USD 384.36M |
| FY2024 | USD 0 | -USD 127.85M | -USD 113.85M | n/a | -1.83 | USD 59.41M | USD 3.18M | USD 243.12M |
| FY2023 | n/a | -USD 100.70M | -USD 86.54M | n/a | -1.96 | USD 23.38M | USD 2.75M | USD 224.09M |
| FY2022 | n/a | -USD 89.12M | -USD 77.22M | n/a | -2.25 | USD 66.84M | USD 2.66M | USD 222.35M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 1.43B | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 805.97M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 573.15M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 501.88M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 264.77M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 579.62M | n/a | n/a | n/a |
About ORIC Pharmaceuticals Inc
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms in cancers in the United States.
Related stock research
Other Healthcare stocks
Adicet Bio Inc (1IJ)
Cartesian Therapeutics, Inc. (1S70)
QUOIN PHARMACEUT.ADR5000 (2EB0)
Aardvark Therapeutics Inc (AARD)
Abeona Therapeutics Inc (ABEO)
Acumen Pharmaceuticals Inc (ABOS)
Absci Corp (ABSI)
Arbutus Biopharma Corp (ABUS)
ABVC BioPharma Inc (ABVC)
Acadia Pharmaceuticals Inc (ACAD)
Adicet Bio Inc (ACET)
Achieve Life Sciences Inc (ACHV)
Frequently asked questions
What is ORIC Pharmaceuticals Inc's market cap?
ORIC Pharmaceuticals Inc's market capitalization is USD 1.43B.
What does ORIC Pharmaceuticals Inc do?
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms in cancers in the United States.